Knott David M Jr »

Cogent Biosciences shares owned by Knott David M Jr

Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.6M 102k 35.52
2025-03-31 $1.3M 213k 5.99

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Syndax Pharmaceutical Common (SNDX)
Xeris Biopharma Holdings Common (XERS)
Travere Therapeutics Common (TVTX)
Bridgebio Pharma Common (BBIO)
Protagonist Therapeutics Common (PTGX)
JPMorgan Chase & Co. Common (JPM)
Janus Henderson AAA CLO ETF Common (JAAA)
Viridian Therapeutics Common (VRDN)
Catalyst Pharmaceuticals Common (CPRX)
Cogent Biosciences Common (COGT)
Mersana Therapeutics Common (MRSN)
Arcus Biosciences Common (RCUS)

View all positions for Knott David M Jr

Top funds holding Cogent Biosciences

FMR
Vanguard Group
BlackRock
Deerfield Management Company
Fairmount Funds Management
Kynam Capital Management
Rtw Investments
TCG Crossover Management
State Street Corporation
Geode Capital Management
Henderson Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Vivo Capital
Octagon Capital Advisors

View all funds holding Cogent Biosciences